CP-690,550 (tofacitinib)
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for CP-690,550 (tofacitinib), covering 2012-12-18 to 2017-06-26. Get the full timeline:
Most recent: Clinical Trial Update: A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis [Phase 3]